Researchers with the National Institute of Allergy and Infectious Diseases (NIAID) recently conducted a study that showed the effectiveness of an experimental vaccine to treat the chikungunya virus.
The results of the study, which showed the production of neutralizing antibodies in all 25 adult volunteers, were published in the current issue of the Lancet.
Common Management Taxonomy:
